Drug · DIN 02563886
TRYNGOLZA
SINGLE-DOSE AUTO-INJECTOR
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 20, 2026; first marketed February 4, 2026.
- Drug Identification Number (DIN)
- 02563886
- Company (DIN owner)
- Celystra Pharma Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Other lipid modifying agents C10AX
- Class
- Human
- Record last updated
- August 17, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| OLEZARSEN (OLEZARSEN SODIUM) | 80 MG | 0.8 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 20, 2026: NOC 37961New Drug Submission (NDS) · Administrative: Change in product ownership
- December 16, 2025: NOC 36553New Drug Submission (NDS)